ACCRO BIOSCIENCE
Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
ACCRO BIOSCIENCE
Industry:
Biotechnology
Founded:
2016-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.accro.com.cn
Status:
Active
Contact:
0512-62626021
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Apache DigiCert SSL Encryption Everywhere Alibaba HiChina DNS
Similar Organizations
Alpha Tau Medical
Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Investors List
Hongtai Capital Holdings
Hongtai Capital Holdings investment in Series B - Accro Bioscience
South China Venture Capital
South China Venture Capital investment in Series B - Accro Bioscience
Shenzhen Capital Group
Shenzhen Capital Group investment in Series B - Accro Bioscience
GF Xinde Investment Management
GF Xinde Investment Management investment in Series B - Accro Bioscience
Morningside Ventures
Morningside Ventures investment in Series B - Accro Bioscience
Oriza Holdings
Oriza Holdings investment in Series B - Accro Bioscience
Official Site Inspections
http://www.accro.com.cn
- Host name: catl.com
- IP address: 203.107.45.167
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Accro Bioscience"
Accro Bioscience - Crunchbase Company Profile
Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis. Search …See details»
Accro Bioscience(Suzhou)Limited
Suzhou China, April 26, 2024 - Accro Bioscience (Suzhou) Limited (Accropeutics), a clinical-stage biotech company with a focus on molecular mechanisms of regulated cell death and related pathogenesis in human …See details»
Org Chart Accro BioScience - The Official Board
The organizational chart of Accro BioScience displays its 5 main executives including Xiaohu Zhang and Bing Wang. ... www.accro.com.cn +86 512 6262 6021; Add an executive. Accro …See details»
Accro BioScience - Overview, News & Similar companies - ZoomInfo
May 24, 2023 Accro BioScience contact info: Phone number: +86 51262626021 Website: www.accro.com.cn What does Accro BioScience do? Accro Bioscience was established in late …See details»
Accro Bioscience Company Profile - Office Locations ... - Craft
Accro Bioscience (爱科诺生物) is a company developing small-molecule drugs designed for inflammatory conditions, autoimmune diseases, and cancer. It focuses on the molecular …See details»
Accro Bioscience(Suzhou)Limited - accropeutics.com
爱科诺生物医药深耕“细胞死亡-炎症”回路，建立了独特的“调节性细胞死亡”新药研发平台。爱科诺研发团队在药物化学、生物学、转化医学等领域积累了丰富的新药研发经验，快速高效地推进多款原创药物进入到临床开发阶段。See details»
Investor Relations - Accro Bioscience (Suzhou) Limited
CN EN. Company History Leadership Investor relations. INVESTOR RELATIONS . The Company was early funded by Morningside Ventures. In December 2021, the Company raised 50M+ …See details»
Culture - Accro Bioscience (Suzhou) Limited - accro.com.cn
Telephone：0512-62626021 Address：Building A1,Biobay,No.218 Xinghu Street,Industrial Park,Suzhou,Jiangsu,P.R.ChinaSee details»
关于爱科诺 - 关于我们 - Accro …
Dr. Henri Nico Doods曾任勃林格殷格翰高级副总裁，也曾担任勃林格殷格翰Research Beyond Border全球负责人。Dr. Doods具有近30年医药研发经验，覆盖心血管、疼痛、肥胖、神经、呼吸等领域，发表超过135篇论文，参与超 …See details»
Accro Bioscience (Suzhou) Co., Ltd. - Drug pipelines, Patents, …
Explore Accro Bioscience (Suzhou) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, Disease Domain:Immune System Diseases, Hemic and Lymphatic …See details»
Accro Bioscience (Suzhou) Co., Ltd. - synapse.zhihuiya.com
了解Accro Bioscience (Suzhou) Co., Ltd. (爱科诺生物医药（苏州）有限公司)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 1篇新闻，疾病领域:免疫系统疾病，血液及淋巴系 …See details»
Accro Bioscience - PitchBook
Accro Bioscience General Information Description. Developer of small molecule innovative drugs designed for inflammatory, autoimmune diseases and cancer. The company focuses on the …See details»
ACCRO
Advancing Health Equity in Africa and the Caribbean ACCRO is a dedicated contract clinical research organization committed to expanding access to innovative diagnostics and therapies …See details»
Asia Cancer Care and Research Organization (ACCRO)
Asia Cancer Care and Research Organization (ACCRO) is a dedicated patient advocacy firm established to tackle cancer as a major health challenge through our innovative philosophy of …See details»
About Accropeutics - About us - Accro Bioscience (Suzhou)Limited
Accropeutics has developed a robust portfolio of innovative compounds spanning from lead optimization to clinical trials. The company's RIPK1 inhibitor AC-003 has completed the Phase …See details»
AC-203 (Accro Bioscience) - Drug Targets, Indications, Patents
Dec 27, 2024 AC-203 (Accro Bioscience), Initially developed by Accro Bioscience (Suzhou) Co., Ltd., Now, its global highest R&D status is IND Application, Therapeutic Areas ...See details»
Associated Canadian Car Rental Operators - ZoomInfo
Jan 4, 2022 Who is Associated Canadian Car Rental Operators. ACCRO - The Associated Canadian Car Rental Operators is a Canadian company dedicated to the continuous …See details»
AC-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
Dec 28, 2024 Accro Bioscience (Suzhou) Co., Ltd. Startup ChiCTR2400089738 / Recruiting Phase 1 IIT Evaluation of the safety, tolerability, pharmacokinetic profile and food effects of AC …See details»
公司新闻 - 新闻媒体 - Accro Bioscience (Suzhou)Limited
2024年4月26日，中国苏州- 爱科诺生物医药（苏州）有限公司今天宣布其候选药物ac-101在健康受试者中进行的临床i期研究顺利完成，并取得积极成果。See details»
AC-003 - Drug Targets, Indications, Patents - Synapse
BACKGROUND The research on cysteine (Cys) determination is deemed as a hot topic, since it has been reported to be connected with various physiological processes and disease …See details»